Mori disease mainly relies on the limitations of drugs and surgery, filling the gap between domestic and foreign.

Parkinson's disease is a worldwide medical problem. There are more than 4 million patients worldwide, China has more than 2 million, and there are nearly 100,000 new people each year. At present, drug treatment can only control the symptoms but not cure, and can not stop or improve the development of the disease. Its increasingly prominent failure phenomenon and adverse reactions have attracted widespread medical attention. Surgical treatment mainly includes destruction surgery, deep brain stimulation and tissue cell transplantation. The damage surgery is not irreversible due to its destruction of the brain nerves, but also produces many complications, and some of them are lifelong disabling, which is no longer advocated; deep brain Electrostimulation, that is, the installation of brain pacemakers, because of the need to implant foreign bodies in the brain and there is a risk, and the cost is high, about 120,000 -26 million, conditional surgery hospitals and patients are very limited, currently China There are less than 2,000 patients undergoing surgical treatment; tissue-cell transplantation using stereotactic techniques to transplant dopaminergic neurons into the brain, such as fetal brain or neural stem cells, is still under investigation.

The Obermatt's Parkson Therapy Instrument Project was awarded a national medical device product registration certificate on January 31, 2011. The research group leader Sun Zuodong is the founder of “brain cell activation theory.” After many years of basic theoretical research and clinical practice in the brain, he proposed a new viewpoint for the treatment of Parkinson’s disease, namely: activation of dopaminergic neurons is The key to the treatment of Parkinson's disease, and led the research team to apply endogenous neurotransmitter regulation technology, finally developed the Obermein Parkinson treatment instrument for five years. The instrument breaks through the limitations of the main dependence on drugs and surgery for the treatment of Parkinson's disease in the world. It is another new method for treating Parkinson's disease and fills gaps at home and abroad.

According to reports, the Oberon Parkinson Therapeutic Apparatus is a science and technology research project in the “Eleventh Five-Year Plan” in Heilongjiang Province. It is particularly suitable for mild to moderate Parkinson's disease and can significantly improve the symptoms of tremors, stiffness, and bradykinesia. The instrument is divided into medical type and household type. Because of its convenient operation, the cost of treatment can be controlled within 20,000 yuan, which is easily accepted by patients. The project has been listed as a major biological engineering project of strategic emerging industries during the “Twelfth Five-Year Plan” period by the Heilongjiang Provincial Government. The Oberauparkinson is a non-invasive treatment that is safe and effective. It is an independent treatment and is particularly suitable for mild to moderate Parkinson's disease. It can significantly improve the symptoms of tremor, rigidity, and bradykinesia.